Location

Rochester, Minnesota

Contact

Bendel-Stenzel.Ellen@mayo.edu Clinical Profile

SUMMARY

Ellen M. Bendel-Stenzel, M.D., is a neonatologist with research interests in fetal intervention therapy, postnatal care of infants after complex prenatal diagnoses, the adaption of emerging neonatal technologies and rapid genetic testing.

Focus areas

  • Fetal therapy. Dr. Bendel-Stenzel founded and co-leads the Fetal Therapy Focus Group of the Children's Hospitals Neonatal Consortium and is active in the North American Fetal Therapy Network. Her research leverages the collective volume of large fetal centers to better understand the impact of in utero interventions on infant outcomes to promote evidence-based practices.
  • Genomics. Dr. Bendel-Stenzel was instrumental in developing a program for universal ultra-rapid whole-genome screening in Mayo Clinic's Neonatal Intensive Care Unit (NICU). This has resulted in earlier diagnoses allowing targeted therapies or a change in clinical care for neonatal patients.
  • Emerging technologies. Dr. Bendel-Stenzel is involved in the multicenterRenal Anhydramnios Fetal Therapy (RAFT) trial, which is funded by the National Institutes of Health (NIH). RAFT facilitated the introduction of the Cardio-Renal Pediatric Dialysis Emergency Machine, the first neonatal dialysis machine approved by the U.S. Food and Drug Administration, to Mayo's NICU. Dr. Bendel-Stenzel leads efforts to create a neonatal hemodynamic team to improve functional echocardiography support in critically ill neonates.

Significance to patient care

Progressive and innovative care is essential to advancing the field of neonatology and improving infant outcomes. Dr. Bendel-Stenzel is passionate about clinical care and finding new opportunities to optimize patient management and improve neonatal outcomes through multicenter collaboration that facilitates both research opportunities and sharing of clinical experience.

Professional highlights

  • Founder and co-lead, Fetal Therapy Focus Group, Children's Hospitals Neonatal Consortium, 2020-present.
  • Member, International Fetal Medicine and Surgery Society, 2014-present.
  • Member, North American Fetal Therapy Network, 2014-present.
  • Member, Belonging Committee (formerly the Equity, Diversity and Inclusion Committee), Department of Pediatric and Adolescent Medicine, Mayo Clinic, 2020-present.
  • Program director and principal investigator, Sleep-disordered breathing in infants with myelomeningocele, National Heart, Lung, and Blood Institute,2020-2025.
  • Program director and principal director, Amend 8 Budget Addendum Letter: AeroFact, AerogenPharma, 2020-2021.

PROFESSIONAL DETAILS

Primary Appointment

  1. Consultant, Division of Neonatal Medicine, Department of Pediatric and Adolescent Medicine

Academic Rank

  1. Associate Professor of Pediatrics

EDUCATION

  1. Fellowship - Neonatology University of Minnesota
  2. Residency - Pediatric University of Minnesota
  3. MD University of Minnesota
  4. BA - Chemistry with a Minor in Mathematics College of St. Catherine

Clinical Studies

Learn about clinical trials that address specific scientific questions about human health and disease.

See my studies.

Explore all research studies at Mayo Clinic.

Publications

See the peer-reviewed findings I have published as a result of my research.

Review publications.
.
BIO-20542192

Mayo Clinic Footer